At Pushpawati Singhania Research Institute, Immunotherapy is delivered through individualized oncology treatment plans and modern diagnostic and therapeutic facilities. Established in 1996, the NABH, NABL accredited hospital in Delhi, India has 201 beds and provides comprehensive cancer care.

Immunotherapy is a form of cancer treatment designed to stimulate or enhance the immune system's ability to fight malignant cells. It may be used alone or combined with treatments such as chemotherapy, radiation therapy, targeted therapy, or surgery, depending on the patient's diagnosis. Treatment is selected according to factors such as cancer type, stage, molecular characteristics, and previous therapies. Regular clinical assessments and laboratory tests help monitor response and safety.